Luisa Cortellazzo Wiel

Luisa Cortellazzo Wiel

Auto-generated profile, based on publicly available information

Luisa Cortellazzo Wiel

University of Trieste, trieste, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2020 in Pediatric Drugs
Verified
Journal Article
Closed access
PDF file
FBFrancesco Baldo
Francesco Baldo
AGAntonio Giacomo Grasso
Antonio Giacomo Grasso
LWLuisa Cortellazzo Wiel
Luisa Cortellazzo Wiel
AMAlessandra Maestro
Alessandra Maestro
MTMarta Paulina Trojniak
Marta Paulina Trojniak
EBEgidio Barbi
Egidio Barbi

12 May 2022 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
LWLuisa Cortellazzo Wiel
Luisa Cortellazzo Wiel
IBIrene Bruno
Irene Bruno
EBEgidio Barbi
Egidio Barbi
FSFabio Sirchia
Fabio Sirchia
Background: Wolf-Hirschhorn syndrome (WHS) is a well-defined disorder, whose core phenotype encompasses growth restriction, facial gestalt, intellectual disability and seizures. Nevertheless, great phenotypic variability exists due to the variable extent of the responsible 4p deletion. In addition, exome sequencing analyses, recently identified two genes, namely NSD2 and NELFA, whose loss-of-function variants contribute to a clinical spectrum consistent with atypical or partial WHS. The observation of patients exhibiting clinical features resembling WHS, with only mild developmental delay and without the typical dysmorphic features, carrying microdeletions sparing NSD2, has lead to the hypothesis that NSD2 is responsible for the intellectual disability and the facial gestalt of WHS. While presenting some of the typical findings of WHS (intellectual disability, facial gestalt, microcephaly, growth restriction and congenital heart defects), NSD2-deleted children tend to display a milder spectrum of skeletal abnormalities, usually consisting of clinodactyly, and do not exhibit seizures. We describe the clinical picture of a child with WHS due to a de novo mutation of NSD2 and discuss the clinical and diagnostic implications. Case presentation: A 6-year-old boy was evaluated for a history of intrauterine growth restriction, low birth weight, neonatal hypotonia, and psychomotor delay. No episodes of seizure were reported. At physical examination, he displayed marphanoid habitus, muscle hypotrophy and facial dysmorphisms consisting in high frontal hairline, upslanting palpebral fissures and full lips with bifid ugula. Cryptorchidism, shawl scrotum, mild clinodactyly of the right little finger and bilateral syndactyly of the II and III toes with sandal gap were also noted. The radiographic essay demonstrated delayed bone age and echocardiography showed mild mitral prolapse. Whole genome sequencing analysis revealed a heterozygous de novo variant of NSD2 (c.2523delG). Conclusions: Full WHS phenotype likely arises from the cumulative effect of the combined haploinsufficiency of several causative genes mapping within the 4p16.3 region, as a contiguous genes syndrome, with slightly different phenotypes depending on the specific genes involved in the deletion. When evaluating children with pictures resembling WHS, in absence of seizures, clinicians should consider this differential diagnosis.

20 August 2020 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
PDF file
LWLuisa Cortellazzo Wiel
Luisa Cortellazzo Wiel
FPFederico Poropat
Federico Poropat
EBEgidio Barbi
Egidio Barbi
GCGiorgio Cozzi
Giorgio Cozzi

14 June 2022 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
PDF file
GCGiorgio Cozzi
Giorgio Cozzi
LWLuisa Cortellazzo Wiel
Luisa Cortellazzo Wiel
AAAlessandro Amaddeo
Alessandro Amaddeo
AGANTONIO GATTO
ANTONIO GATTO
MGManuela Giangreco
Manuela Giangreco
ASAleksandar Sovtic
Aleksandar Sovtic
Background Bronchiolitis is the leading acute respiratory tract infection in infants during the winter season. Since the beginning of the SARS-CoV-2 pandemic, a reduction in the number of bronchiolitis diagnoses has been registered. Objective The present study aimed to describe the incidence and clinical features of bronchiolitis during the 2020–2021 winter season in a large cohort of children in Europe and Israel, and to clarify the role of SARS-CoV-2. Setting, patients, interventions We conducted a multicentre observational cross-sectional study in 23 paediatric emergency departments in Europe and Israel. Clinical and demographic data about all the cases of infants diagnosed with bronchiolitis from 1 October 2020 to 30 April 2021 were collected. For each enrolled patient, diagnostic tests, treatments and outcomes were reported. Main outcome measures The main outcome was the prevalence of SARS-CoV-2-positive bronchiolitis. Results Three hundred and fourteen infants received a diagnosis of bronchiolitis during the study period. Among 535 infants who tested positive for SARS-CoV-2, 16 (3%) had bronchiolitis. Median age, male sex predominance, weight, history of prematurity and presence of comorbidities did not differ between the SARS-CoV-2-positive and SARS-CoV-2-negative groups. Rhinovirus was the most common involved pathogen, while respiratory syncytial virus (RSV) was detected in one case. SARS-CoV-2 bronchiolitis had a mild clinical course, with one patient receiving oxygen supplementation and none requiring paediatric or neonatal intensive care unit admission. Conclusions During the SARS-CoV-2 pandemic, a marked decrease in the number of bronchiolitis diagnoses and the disappearance of the RSV winter epidemic were observed. SARS-CoV-2-related bronchiolitis was rare and mostly displayed a mild clinical course.

19 April 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
FAFederica Anastasia
Federica Anastasia
LWLuisa Cortellazzo Wiel
Luisa Cortellazzo Wiel
MGManuela Giangreco
Manuela Giangreco
GMGiuliana Morabito
Giuliana Morabito
PRPatrizia Romito
Patrizia Romito
CGClaudio Germani
Claudio Germani

2 May 2023 in Archives of Disease in Childhood
Verified
Journal Article
Open access
PDF file
GCGiorgio Cozzi
Giorgio Cozzi
ASAleksandar Sovtic
Aleksandar Sovtic
DGDavide Garelli
Davide Garelli
UKUros Krivec
Uros Krivec
DSDavide Silvagni
Davide Silvagni
LWLuisa Cortellazzo Wiel
Luisa Cortellazzo Wiel
Background Bronchiolitis is the main acute lower respiratory tract infection in infants. Data regarding SARS-CoV-2-related bronchiolitis are limited. Objective To describe the main clinical characteristics of infants with SARS-CoV-2-related bronchiolitis in comparison with infants with bronchiolitis associated with other viruses. Setting, patients, interventions A multicentre retrospective study was conducted in 22 paediatric emergency departments (PED) in Europe and Israel. Infants diagnosed with bronchiolitis, who had a test for SARS-CoV-2 and were kept in clinical observation in the PED or admitted to hospital from 1 May 2021 to 28 February 2022 were considered eligible for participation. Demographic and clinical data, diagnostic tests, treatments and outcomes were collected. Main outcome measures The main outcome was the need for respiratory support in infants testing positive for SARS-CoV-2 compared with infants testing negative. Results 2004 infants with bronchiolitis were enrolled. Of these, 95 (4.7%) tested positive for SARS-CoV-2. Median age, gender, weight, history of prematurity and presence of comorbidities did not differ between the SARS-CoV-2-positive and SARS-CoV-2-negative infants. Human metapneumovirus and respiratory syncytial virus were the viruses most frequently detected in the group of infants negative for SARS-CoV-2. Infants testing positive for SARS-CoV-2 received oxygen supplementation less frequently compared with SARS-CoV-2-negative patients, 37 (39%) vs 1076 (56.4%), p=0.001, OR 0.49 (95% CI 0.32 to 0.75). They received less ventilatory support: 12 (12.6%) high flow nasal cannulae vs 468 (24.5%), p=0.01; 1 (1.0%) continuous positive airway pressure vs 125 (6.6%), p=0.03, OR 0.48 (95% CI 0.27 to 0.85). Conclusions SARS-CoV-2 rarely causes bronchiolitis in infants. SARS-CoV-2-related bronchiolitis mostly has a mild clinical course.